Cross-sectional and longitudinal analysis of cancer vaccination trials registered on the US Clinical Trials Database demonstrates paucity of immunological trial endpoints and decline in registration since 2008

INTRODUCTION: Cancer vaccination has been researched as a means of treating and preventing cancer, but successful translational efforts yielding clinical therapeutics have been limited. Numerous reasons have been offered in explanation, pertaining both to the vaccine formulation, and the clinical tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Liangjian, Yan, Haixi, Shyam-Sundar, Vijay, Janowitz, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189706/
https://www.ncbi.nlm.nih.gov/pubmed/25302014
http://dx.doi.org/10.2147/DDDT.S65963

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4189706/
https://www.ncbi.nlm.nih.gov/pubmed/25302014
http://dx.doi.org/10.2147/DDDT.S65963

Ejemplares similares